Abstract
This paper navigates through diverse sectors, starting with real estate, where value investing demands a nuanced understanding of unique challenges, such as low liquidity and strategic leverage use. The technology sector, with its disruptive innovations, challenges traditional investment paradigms. Examples like Amazon reshaping retail underscore how disruptive technologies erode value in traditional sectors. In healthcare, the impact of clinical trial results on stock performance is dissected using Moderna and Pfizer as case studies, highlighting the sector's asymmetrical response to positive and negative outcomes. This paper concludes by addressing the limitations of value investing, emphasizing challenges related to time horizon, industry dynamism, and market efficiency assumptions. This paper advocates for a balanced approach combining historical wisdom with adaptability in a dynamic market landscape. Acknowledging the limitations, investors are encouraged to embrace a forward-looking mindset, recognizing the evolving nature of industries. The resilience of value investing lies in its storied past and its ability to adapt, offering a guiding philosophy for modern investors navigating multifaceted financial terrains.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Economics, Management and Political Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
